Association of p53 and MDM2 polymorphisms with risk of human papillomavirus (HPV)-related esophageal squamous cell carcinoma (ESCC)

Cancer Epidemiology

Volumn 37, Issue 5, 2013, Pages 629-633

  Yang, Ju ^a   Liu, Bo ^a   Li, Wen ^a   Xiong, Huihua ^a   Qiu, Hong ^a   Fu, Qiang ^a   Chen, Bei ^b   Hu, Guangyuan ^a   Yuan, Xianglin ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b Tumor Hospital of Hubei Province   (China)

Author keywords

Drinking; ESCC; HPV; MDM2; P53; Polymorphism; Smoking

Indexed keywords

PROTEIN MDM2; PROTEIN P53;

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DRINKING BEHAVIOR; ENZYME LINKED IMMUNOSORBENT ASSAY; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENOTYPE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; MAJOR CLINICAL STUDY; MALE; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING;

DRINKING; ESCC; HPV; MDM2; P53; POLYMORPHISM; SMOKING;

ALCOHOL DRINKING; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CHINA; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS C-MDM2; SMOKING; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84884155288     PISSN: 18777821     EISSN: 1877783X     Source Type: Journal    
DOI: 10.1016/j.canep.2013.06.001     Document Type: Article

References (33)

1. Jemal A., Bray F., Center M.M., Ferlay J., Ward E., Forman D. Global cancer statistics. CA Cancer J Clin 2011, 61:69-90.
2. Enzinger P.C., Mayer R.J. Esophageal cancer. N Engl J Med 2003, 349:2241-2252.
3. Islami F., Boffetta P., Ren J.S., Pedoeim L., Khatib D., Kamangar F. High-temperature beverages and foods and esophageal cancer risk - a systematic review. Int J Cancer 2009, 125:491-524.
4. Syrjanen K., Pyrhonen S., Aukee S., Koskela E. Squamous cell papilloma of the esophagus: a tumour probably caused by human papilloma virus (HPV). Diagn Histopathol 1982, 5:291-296.
5. Shuyama K., Castillo A., Aguayo F., Sun Q., Khan N., Koriyama C., et al. Human papillomavirus in high- and low-risk areas of oesophageal squamous cell carcinoma in China. Br J Cancer 2007, 96:1554-1559.
6. Munoz N., Bosch F.X., de Sanjose S., Herrero R., Castellsague X., Shah K.V., et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003, 348:518-527.
7. Marur S., D'Souza G., Westra W.H., Forastiere A.A. HPV-associated head and neck cancer: a virus-related cancer epidemic. Lancet Oncol 2010, 11:781-789.
8. Qi Z., Jiang Q., Yang J., Chen X., Wu H., Huang L., et al. Human papillomavirus (HPV) infection and the risk of esophageal squamous cell carcinoma. Dis Esophagus 2013, 26:61-67.
9. Soussi T., Beroud C. Assessing TP53 status in human tumours to evaluate clinical outcome. Nat Rev Cancer 2001, 1:233-240.
10. Matlashewski G.J., Tuck S., Pim D., Lamb P., Schneider J., Crawford L.V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol Cell Biol 1987, 7:961-963.
11. Storey A., Thomas M., Kalita A., Harwood C., Gardiol D., Mantovani F., et al. Role of a p53 polymorphism in the development of human papillomavirus-associated cancer. Nature 1998, 393:229-234.
12. Zehbe I., Voglino G., Wilander E., Genta F., Tommasino M. Codon 72 polymorphism of p53 and its association with cervical cancer. Lancet 1999, 354:218-219.
13. Kawaguchi H., Ohno S., Araki K., Miyazaki M., Saeki H., Watanabe M., et al. p53 polymorphism in human papillomavirus-associated esophageal cancer. Cancer Res 2000, 60:2753-2755.
14. Yang W., Zhang Y., Tian X., Ning T., Ke Y. p53 Codon 72 polymorphism and the risk of esophageal squamous cell carcinoma. Mol Carcinog 2008, 47:100-104.
15. Hong Y., Miao X., Zhang X., Ding F., Luo A., Guo Y., et al. The role of P53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma. Cancer Res 2005, 65:9582-9587.
16. Lee J.M., Lee Y.C., Yang S.Y., Shi W.L., Lee C.J., Luh S.P., et al. Genetic polymorphisms of p53 and GSTP1,but not NAT2,are associated with susceptibility to squamous-cell carcinoma of the esophagus. Int J Cancer 2000, 89:458-464.
17. Michael D., Oren M. The p53-Mdm2 module and the ubiquitin system. Semin Cancer Biol 2003, 13:49-58.
18. Chen J., Wu X., Lin J., Levine A.J. mdm-2 inhibits the G1 arrest and apoptosis functions of the p53 tumor suppressor protein. Mol Cell Biol 1996, 16:2445-2452.
19. Haupt Y., Barak Y., Oren M. Cell type-specific inhibition of p53-mediated apoptosis by mdm2. EMBO J 1996, 15:1596-1606.
20. Chen X., Sturgis E.M., Lei D., Dahlstrom K., Wei Q., Li G. Human papillomavirus seropositivity synergizes with MDM2 variants to increase the risk of oral squamous cell carcinoma. Cancer Res 2010, 70:7199-7208.
21. Gao Y.T., McLaughlin J.K., Blot W.J., Ji B.T., Benichou J., Dai Q., et al. Risk factors for esophageal cancer in Shanghai, China. I: role of cigarette smoking and alcohol drinking. Int J Cancer 1994, 58:192-196.
22. Sitas F., Egger S., Urban M.I., Taylor P.R., Abnet C.C., Boffetta P., et al. InterSCOPE study: associations between esophageal squamous cell carcinoma and human papillomavirus serological markers. J Natl Cancer Inst 2012, 104:147-158.
23. Islami F., Fedirko V., Tramacere I., Bagnardi V., Jenab M., Scotti L., et al. Alcohol drinking and esophageal squamous cell carcinoma with focus on light-drinkers and never-smokers: a systematic review and meta-analysis. Int J Cancer 2011, 129:2473-2484.
24. Sonoda Y., Saigo P.E., Boyd J. p53 and genetic susceptibility to cervical cancer. J Natl Cancer Inst 1999, 91:557.
25. Dahabreh I.J., Linardou H., Bouzika P., Varvarigou V., Murray S. TP53 Arg72Pro polymorphism and colorectal cancer risk: a systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev 2010, 19:1840-1847.
26. Donehower L.A., Harvey M., Slagle B.L., McArthur M.J., Montgomery C.A., Butel J.S., et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992, 356:215-221.
27. Malkin D., Li F.P., Strong L.C., Fraumeni J.F., Nelson C.E. Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms. Science 1990, 250:1233-1238.
28. Freedman D.A., Levine A.J. Regulation of the p53 protein by the MDM2 oncoprotein - thirty-eighth G.H.A. Clowes Memorial Award Lecture. Cancer Res 1999, 59:1-7.
29. Rampias T., Sasaki C., Weinberger P., Psyrri A. E6 and e7 gene silencing and transformed phenotype of human papillomavirus 16-positive oropharyngeal cancer cells. J Natl Cancer Inst 2009, 101:412-423.
30. DeMarini D.M. Genotoxicity of tobacco smoke and tobacco smoke condensate: a review. Mutat Res 2004, 567:447-474.
31. Blot W.J., McLaughlin J.K. The changing epidemiology of esophageal cancer. Semin Oncol 1999, 26:2-8.
32. Brown L.M., Devesa S.S. Epidemiologic trends in esophageal and gastric cancer in the United States. Surg Oncol Clin N Am 2002, 11:235-256.
33. Lee C.H., Lee J.M., Wu D.C., Hsu H.K., Kao E.L., Huang H.L., et al. Independent and combined effects of alcohol intake, tobacco smoking and betel quid chewing on the risk of esophageal cancer in Taiwan. Int J Cancer 2005, 113:475-482.